ZA200110539B - Oxazinocarbazoles for the treatment of CNS diseases. - Google Patents

Oxazinocarbazoles for the treatment of CNS diseases.

Info

Publication number
ZA200110539B
ZA200110539B ZA200110539A ZA200110539A ZA200110539B ZA 200110539 B ZA200110539 B ZA 200110539B ZA 200110539 A ZA200110539 A ZA 200110539A ZA 200110539 A ZA200110539 A ZA 200110539A ZA 200110539 B ZA200110539 B ZA 200110539B
Authority
ZA
South Africa
Prior art keywords
oxazinocarbazoles
treatment
cns diseases
cns
diseases
Prior art date
Application number
ZA200110539A
Other languages
English (en)
Inventor
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA200110539B publication Critical patent/ZA200110539B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA200110539A 1999-07-28 2001-12-21 Oxazinocarbazoles for the treatment of CNS diseases. ZA200110539B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14601399P 1999-07-28 1999-07-28

Publications (1)

Publication Number Publication Date
ZA200110539B true ZA200110539B (en) 2003-03-24

Family

ID=22515535

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200110539A ZA200110539B (en) 1999-07-28 2001-12-21 Oxazinocarbazoles for the treatment of CNS diseases.

Country Status (20)

Country Link
US (2) US6448397B1 (xx)
EP (1) EP1200447B1 (xx)
JP (1) JP2003506328A (xx)
KR (1) KR20020015079A (xx)
CN (1) CN1165539C (xx)
AR (1) AR024963A1 (xx)
AT (1) ATE251167T1 (xx)
AU (1) AU767282B2 (xx)
BR (1) BR0012791A (xx)
CA (1) CA2376927A1 (xx)
CO (1) CO5031298A1 (xx)
DE (1) DE60005685T2 (xx)
DK (1) DK1200447T3 (xx)
ES (1) ES2208371T3 (xx)
MX (1) MXPA02000984A (xx)
PE (1) PE20010548A1 (xx)
PT (1) PT1200447E (xx)
TW (1) TWI222450B (xx)
WO (1) WO2001009142A1 (xx)
ZA (1) ZA200110539B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100497122B1 (ko) * 2001-08-30 2005-06-29 주식회사 삼양제넥스 페놀옥시다제 시스템을 구성하는 단백질 및 그것의 유전자
SE0103539D0 (sv) * 2001-10-23 2001-10-23 Biovitrum Ab New Use
WO2003039547A1 (en) * 2001-11-09 2003-05-15 Biovitrum Ab Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake
EP1495031A1 (en) * 2002-04-16 2005-01-12 Pharmacia & Upjohn Company LLC Labeled oxazinocarbazoles as diagnostic agents
US6932961B1 (en) 2002-04-16 2005-08-23 Pharmacia & Upjohn Company Oxazinocarbazoles for the treatment of CNS diseases
TWI284124B (en) * 2002-12-03 2007-07-21 Hoffmann La Roche Aminoalkoxyindoles
MX2008013053A (es) * 2006-04-12 2008-10-17 Wyeth Corp Derivados de dihidri[1,4]oxazino[2,3,4-hi]indazol-sustituidos como ligandos de 5-hidroxitriptamina-6.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
AU7949694A (en) 1993-10-20 1995-05-08 Tokyo Tanabe Company Limited Indole derivative
EP0985671B1 (en) 1996-05-31 2003-04-02 Mochida Pharmaceutical Co., Ltd. PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT

Also Published As

Publication number Publication date
CO5031298A1 (es) 2001-04-27
JP2003506328A (ja) 2003-02-18
MXPA02000984A (es) 2002-07-30
CA2376927A1 (en) 2001-02-08
PT1200447E (pt) 2004-02-27
BR0012791A (pt) 2002-06-18
US6448397B1 (en) 2002-09-10
ATE251167T1 (de) 2003-10-15
US6821970B2 (en) 2004-11-23
TWI222450B (en) 2004-10-21
KR20020015079A (ko) 2002-02-27
AU767282B2 (en) 2003-11-06
DK1200447T3 (da) 2004-02-02
EP1200447B1 (en) 2003-10-01
US20020169317A1 (en) 2002-11-14
EP1200447A1 (en) 2002-05-02
WO2001009142A1 (en) 2001-02-08
AR024963A1 (es) 2002-10-30
DE60005685T2 (de) 2004-08-12
ES2208371T3 (es) 2004-06-16
AU6219700A (en) 2001-02-19
DE60005685D1 (de) 2003-11-06
CN1361781A (zh) 2002-07-31
PE20010548A1 (es) 2001-05-13
CN1165539C (zh) 2004-09-08

Similar Documents

Publication Publication Date Title
MXPA03002814A (es) Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL196301A0 (en) Medicament for the treatment of hapatitis c
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
ZA200202461B (en) Compounds for the treatment of ischemia.
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
ZA200003236B (en) Combination therapy for the treatment of migraine.
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
ZA200105690B (en) Novel treatment.
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
IL133760A0 (en) Composition for the treatment of dandruff
MXPA03001472A (es) Compuestos para el tratamiento de trastornos adictivos.
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
MXPA03004454A (es) Derivados de imidazolona para el tratamiento de enfermedades virales.
HU0001891D0 (en) Medicament for the treatment of migraine
ZA200003235B (en) Combination therapy for the treatment of migraine.
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
ZA991786B (en) Therapeutic treatment for asthma.
ZA200002343B (en) Combination therapy for the treatment of migraine.
ZA200101058B (en) Process for the treatment of gases.